Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| content:anakinra [2020/02/14 17:42] – created icna | content:anakinra [2022/04/30 11:31] (current) – administrator@icnapedia.org | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Anakinra ====== | ====== Anakinra ====== | ||
| Anakinra is a recombinant human interleukin-1 receptor antagonist (IL-1Ra). It competitively inhibits binding of IL-1α and IL-1β to the IL-1 receptor type 1. Given daily as subcutaneous injection, it has modest but significant anti-inflammatory efficacy in Rheumatoid arthritis and has been proven of particular benefit in autoinflammatory syndromes, where IL-1 seems to play a pivotal role. | Anakinra is a recombinant human interleukin-1 receptor antagonist (IL-1Ra). It competitively inhibits binding of IL-1α and IL-1β to the IL-1 receptor type 1. Given daily as subcutaneous injection, it has modest but significant anti-inflammatory efficacy in Rheumatoid arthritis and has been proven of particular benefit in autoinflammatory syndromes, where IL-1 seems to play a pivotal role. | ||
| + | |||
| + | Anakinra has been reported to be useful in refractory seizures in the chronic phase of [[FIRES]][(: | ||
| + | |||
| + | ===== References ===== | ||
| + | |||
| + | ~~REFNOTES~~ | ||